Advanced search
Publication Cover
Future Science OA Volume 1, 2015 - Issue 4
Submit an article Journal homepage
1,521
Views
10
CrossRef citations to date
0
Altmetric
Case Report

Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor

Thomas Grellety1 Department of Medical Oncology, Institut Bergonié, Bordeaux, FranceView further author information
,
Michèle Kind2 Department of Radiology, Institut Bergonié, Bordeaux, FranceView further author information
,
Jean-Michel Coindre3 Department of Pathology, Institut Bergonié, Bordeaux, FranceView further author information
&
Antoine Italiano1 Department of Medical Oncology, Institut Bergonié, Bordeaux, FranceCorrespondence[email protected]
View further author information
Article: FSO33 | Published online: 24 Jun 2015

Figures & data

Figure 1.  Response to regorafenib of a PDGFRA mutated GIST. Response to regorafenib in a patient with liver metastasis (A, B, C) before treatment; (D, E, F) response maintained 18 months after treatment onset) from a PDGFRA exon 18 mutated gastrointestinal stromal tumor.

Figure 1.  Response to regorafenib of a PDGFRA mutated GIST. Response to regorafenib in a patient with liver metastasis (A, B, C) before treatment; (D, E, F) response maintained 18 months after treatment onset) from a PDGFRA exon 18 mutated gastrointestinal stromal tumor.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.